Results Capturing in vivo HIV genome RNA structure in infected cells and in virion To effectively capture and analyze full-length low abundant HIV RNA-RNA interactions in infected cells, we developed ...

Since 1995, National HIV Testing Day has raised awareness and confronted stereotypes about HIV. Learn about HIV testing options and prevention methods.

HIV/AIDS : Welcome to Medscape HIV/AIDS, where you can peruse the latest medical news, commentary from clinician experts, major conference coverage, full-text journal articles, and trending stories.

HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the young. New research reveals older adults face comparable or higher ...

FDA approves twice-a-year HIV prevention drug that could help end the virus worldwide It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

While a vaccine to prevent HIV still is needed, some experts say the shot made by Gilead Sciences — a drug called lenacapavir — could be the next best thing.

Models indicate that the worst-case scenario of the Trump administration's HIV-related cuts could result in 3 million deaths.

Stay up to date with Charles Louis Eugène Virion (French, 1865 - 1946) . Discover works for sale, auction results, market data, news and exhibitions on MutualArt.

While a vaccine to prevent HIV still is needed, some experts say the new shot could be the next best thing.

Christine Teague, CAMC Ryan White Program Director, told MetroNews that National HIV Testing Day was first established in 1995, marking its 30th year this year.

In partnership with the Pulitzer Center, William Brangham reports on the impact USAID cuts are having on HIV testing and treatment in Kenya.

WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's ...